APPLICATION
ANDA205873
TYPE
ANDA
ORIGINAL APPROVAL
2017-06-16
LATEST ACTION
2025-05-23
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CISATRACURIUM BESYLATEDiscontinued
CISATRACURIUM BESYLATE EQ 2MG BASE/ML · INJECTABLE · INJECTION
Approval history
2025-05-23Labeling · Supplement 5 · standardAP
2017-06-16UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.